Advanced Liver Cancer Clinical Trial
Official title:
A Phase I, Open-label, Dose Escalation Study to Evaluate the Safety ,Tolerance and Pharmacokinetics of OH2 Via Transcatheter Intraarterial Infusion in Patients With Advanced Liver Cancer
An open-label dose-escalation phase I clinical study to evaluate the safety, tolerability and pharmacokinetics of OH2 injection via transcatheter Intraarterial infusion in patients with advanced hepatocellular carcinoma
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01754987 -
A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03146637 -
Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer
|
Phase 2 | |
| Withdrawn |
NCT03484962 -
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer
|
Phase 2 | |
| Recruiting |
NCT05603039 -
A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04906434 -
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
|
Phase 1 | |
| Recruiting |
NCT04163237 -
Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer
|
Phase 3 | |
| Recruiting |
NCT02862613 -
Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02873442 -
Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03474822 -
Plasmodium Immunotherapy for Breast and Liver Cancers
|
Phase 1/Phase 2 |